The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.0M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 695K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

7 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Heteroaromatic compounds as BTK inhibitorsBDB
Boehringer Ingelheim International
8-(piperazin-1-yl)-1,2,3,4-tetrahydro-isoquinoline derivativesBDB
Idorsia Pharmaceuticals
Splicing factor SF3b as a target of the antitumor natural product pladienolide.BDB
Eisai
Discovery of begacestat, a Notch-1-sparing gamma-secretase inhibitor for the treatment of Alzheimer's disease.BDB
Wyeth Research
Design and synthesis of 2-amino-pyrazolopyridines as Polo-like kinase 1 inhibitors.BDB
Sunesis Pharmaceuticals
Inhibitors of the tyrosine kinase EphB4. Part 1: Structure-based design and optimization of a series of 2,4-bis-anilinopyrimidines.BDB
Astrazeneca
Pharmacological and functional comparison of the polo-like kinase family: insight into inhibitor and substrate specificity.BDB
Abbott Laboratories